IRulya Therapeutics Inc. vs Regenxbio Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Regenxbio Inc. is the larger company by market value: $513 M against $343 M for IRulya Therapeutics Inc., 1.5 times as much (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Oct 6, 2026 for Regenxbio Inc.).
- Both made a net loss: $84 M for IRulya Therapeutics Inc. and $194 M for Regenxbio Inc.
- Regenxbio Inc. employs more people: 372 against 55 at IRulya Therapeutics Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | IRulya Therapeutics Inc. IRLA · #14,231 in the world | Regenxbio Inc. RGNX · #12,428 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $343 M | $513 M |
| Revenue | — | $170 M |
| Net income | $-84 M▲ best | $-194 M |
| Employees | 55 | 372 |
| Valuation | ||
| Price to sales | — | 3.3× |
| Price to book | — | 5.0× |
| Free cash flow yield | -12.2%▲ best | -24.6% |
| Profitability | ||
| Operating margin | — | -94.6% |
| Net margin | — | -113.8% |
| Return on equity | — | -107.0% |
| Growth | ||
| Revenue growth | — | 104.5% |
| Revenue growth, 3 years a year | — | 14.8% |
| Cash | ||
| Free cash flow margin | — | -74.1% |
| Altman Z-score zone | — | distress |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, IRulya Therapeutics Inc. or Regenxbio Inc.?
Regenxbio Inc. is the larger company by market value: $513 M against $343 M for IRulya Therapeutics Inc., 1.5 times as much (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Oct 6, 2026 for Regenxbio Inc.).
Which makes more money, IRulya Therapeutics Inc. or Regenxbio Inc.?
Both made a net loss: $84 M for IRulya Therapeutics Inc. and $194 M for Regenxbio Inc.
Which has more employees, IRulya Therapeutics Inc. or Regenxbio Inc.?
Regenxbio Inc. employs more people: 372 against 55 at IRulya Therapeutics Inc.
More about IRulya Therapeutics Inc.
More about Regenxbio Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.